BMJ Publishing Group, BMJ, 7518(331), p. 673-677, 2005
Full text: Download
Writing this article enabled Matthew Walker to revisit the few randomised controlled trials of status epilepticus. This confirmed how poor the data are and that there is little evidence to support one treatment regimen over another.